FDA Releases Transparency Roadmap Outlining Disclosure Priorities Across Drug Development and Regulatory Review

The feed reports that FDA's acting chief of staff has outlined disclosure progress and priorities in an FDA Voices post concerning drug development and review. Topics include complete response letters, application stages, new approach methodologies, labeling and inspection records.